PLSEPulse Biosciences, Inc.

PLSE Stock Price, Valuation & Chart | Pulse Biosciences, Inc.

Compare

$52.680+0.59 (+1.13%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Instruments & Supplies PLSE intrinsic value PLSE calculated fair value vs price

Overview Financials Dividends Ratios

PLSE Historical price chart

PLSE Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization3.65B

PE Ratio-44.64

EPS-1.18

Trading Volume977.76K

Today's High/Low53.57/51.51

Dividend Yield0.00

52 Week High/Low54.39/12.56

Shares Outstanding69.21M

PLSE Financial Statement

PLSE Analyst ratings

PLSE Analysis & performance metrics

PLSE Company profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano…

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The…

PLSE Management team

Name

Position

Mitchell E. Levinson

Chief Strategy Officer

Paul Arthur LaVioletteCEO

President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer & Co-Chairman of the Board

Jon SkinnerCFO

Chief Financial Officer

Darrin R. UeckerCTO

Chief Technology Officer & Director

Richard Nuccitelli Ph.D.

Chief Science Officer

Robert W. Duggan

Independent Co-Chairman

Kevin P. Danahy

Chief Commercial Officer & Principal Executive Officer

Edison Manuel

Vice President of Operations

Name

Position

Mitchell E. Levinson

Chief Strategy Officer

Paul Arthur LaVioletteCEO

President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer & Co-Chairman of the Board

Jon SkinnerCFO

Chief Financial Officer

Darrin R. UeckerCTO

Chief Technology Officer & Director

Richard Nuccitelli Ph.D.

Chief Science Officer

Robert W. Duggan

Independent Co-Chairman

Kevin P. Danahy

Chief Commercial Officer & Principal Executive Officer

Edison Manuel

Vice President of Operations

Management Team

Mitchell E. Levinson

Chief Strategy Officer

Paul Arthur LaVioletteCEO

President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer & Co-Chairman of the Board

Jon SkinnerCFO

Chief Financial Officer

Darrin R. UeckerCTO

Chief Technology Officer & Director

Richard Nuccitelli Ph.D.

Chief Science Officer

Robert W. Duggan

Independent Co-Chairman

Kevin P. Danahy

Chief Commercial Officer & Principal Executive Officer

Edison Manuel

Vice President of Operations

Management

Mitchell E. Levinson

Chief Strategy Officer

Paul Arthur LaVioletteCEO

President, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer & Co-Chairman of the Board

Jon SkinnerCFO

Chief Financial Officer

Darrin R. UeckerCTO

Chief Technology Officer & Director

Richard Nuccitelli Ph.D.

Chief Science Officer

Robert W. Duggan

Independent Co-Chairman

Kevin P. Danahy

Chief Commercial Officer & Principal Executive Officer

Edison Manuel

Vice President of Operations

Total 8 executives

PLSE Frequently asked questions

What is Pulse Biosciences, Inc. (PLSE) Stock Price?

Current stock price of Pulse Biosciences, Inc. (PLSE) stock is $52.680. The stock price is +1.13% higher in the session. The intraday range can be seen from this page. Volume of Pulse Biosciences, Inc. (PLSE) stock is 977.76K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Pulse Biosciences, Inc. (PLSE) stock price going up or down today?

The stock price of Pulse Biosciences, Inc. (PLSE) can change with earnings, company news, and overall market sentiment. Pulse Biosciences, Inc. operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Pulse Biosciences, Inc. stock expensive at its current price?

Whether Pulse Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PLSE on this page is -44.64. EPS on this page is -1.18. Compare those figures with peers and growth expectations before deciding if the current Pulse Biosciences, Inc. price is justified.

How has the stock price of Pulse Biosciences, Inc. (PLSE) performed historically?

Historical performance for Pulse Biosciences, Inc. (PLSE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PLSE reacted to past earnings and market events.

Should I buy Pulse Biosciences, Inc. (PLSE) stock, at this price?

Buying Pulse Biosciences, Inc. (PLSE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.